legalization

A recent statistical analysis from the publication Quartz Advisors found that traffic fatalities declined or remained constant after states adopted recreational cannabis laws. The analysis—focused on four states that legalized marijuana…

What are the five cannabis stories you might have missed? Nowadays, it’s impossible to keep up with cannabis news stories across the world. Whether it’s banking reform and rescheduling in the United States, legalization in Europe or…

What is Vivek Ramaswamy’s position on cannabis? “You don’t hear me talk about the war on drugs. I’m not a war on drugs person,” Ramaswamy said when he appeared at a Free State Project event in New Hampshire last June.Vivek Ramaswamy is…

Regulating cannabis like fish? Excuse me, what? According to Leah Heise, the cannabis industry can learn much from commercial fishing.An accomplished cannabis exec, Leah’s been the CAO of Ascend Wellness Holdings, the CEO of Women Grow,…

The SAFER Banking Act has passed a critical Senate Committee hearing with a vote of 14-9. The renamed bipartisan bill would allow banks to work with cannabis businesses without penalties from the federal government.The U.S. cannabis…

What is the Journeymen Collective magic mushroom retreat? Contemporary shamans Gary Logan and Rob Grover sat down with CLN the other day to discuss what really happens in a psychedelic treat.Is it a type of psychedelic therapy? Not…

US cannabis legalization in the 2024 election? Will Joe Biden and the Democrats make cannabis reform a significant part of their re-election platform?With the potential rescheduling of cannabis from Schedule I to III, pot stocks have…

A British Columbia (B.C.) court dismissed a lawsuit from owners of licensed cannabis retail shops. Last year, this group of cannabis retailers sued the province for not enforcing cannabis regulations.While licensed cannabis retailers…

A recently published retrospective study suggests medical cannabis reduces neuropathic pain without serious side effects.Algea Care, Europe’s leading telemedicine platform for medical cannabis, conducted the study in cooperation with the…

“Tilray is too dangerous,” said CNBC’s “Mad Money” host Jim Cramer. “It is a spec stock that is losing money, and we don’t recommend stocks that are losing money.”Cramer isn’t the only one shying away from the Canadian cannabis producer.…